Andrea Klumpp
Overview
Explore the profile of Andrea Klumpp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klumpp A, Zampetaki A, Schmelcher P
Phys Rev E
. 2018 Jan;
96(3-1):032227.
PMID: 29346977
We investigate the nonequilibrium dynamics of coupled Coulomb crystals of different sizes trapped in a double well potential. The dynamics is induced by an instantaneous quench of the potential barrier...
2.
Hermisson M, Klumpp A, Wick W, Wischhusen J, Nagel G, Roos W, et al.
J Neurochem
. 2006 Jan;
96(3):766-76.
PMID: 16405512
Temozolomide (TMZ) is a methylating agent which prolongs survival when administered during and after radiotherapy in the first-line treatment of glioblastoma and which also has significant activity in recurrent disease....
3.
Steinbach J, Wolburg H, Klumpp A, Weller M
J Neurochem
. 2005 Mar;
92(6):1340-9.
PMID: 15748153
Death ligands such as CD95 ligand (CD95L) have limited activity against glioma cells under normoxic conditions. Hypoxia is a critical aspect of the microenvironment of gliomas in vivo. We investigated...
4.
Steinbach J, Eisenmann C, Klumpp A, Weller M
Biochem Biophys Res Commun
. 2004 Sep;
321(3):524-30.
PMID: 15358139
Inhibition of epidermal growth factor receptor (EGFR) signaling sensitizes human malignant glioma cells to death ligand-induced apoptosis. However, tumor cells may compensate the loss of EGFR signaling by activation of...
5.
Steinbach J, Klumpp A, Wolburg H, Weller M
Cancer Res
. 2004 Mar;
64(5):1575-8.
PMID: 14996711
Epidermal growth factor receptor (EGFR) signaling has become an important target for drug development because EGFR signaling enhances tumor cell proliferation, migration, and invasion and inhibits apoptosis. However, the results...